Dr. Michele Lambert, M.D.
Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Hem/onc
Philadelphia, PA 19104
At a glance
- Medical school
- Rutgers New Jersey Medical School (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: Rutgers New Jersey Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Hematology & Oncology Physician primary
PA license MD417453 -
Pediatrics Physician
PA license MD417453
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Childrens Health Care Associates Inc (220 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 4 companies reported 10 payments worth $17,024 in total to this clinician.
| Sobi, Inc | $7,917 |
|---|---|
| Argenx US, Inc. | $5,625 |
| Janssen Research & Development, LLC | $3,438 |
| Imperative Care, Inc | $44.93 |
| Consulting Fee | $15,751 |
|---|---|
| Travel and Lodging | $1,101 |
| Food and Beverage | $172 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sobi, Inc Apr 10, 2025 | Consulting Fee Doptelet · Hematology/Oncology | $6,689 |
| Argenx US, Inc. Feb 19, 2025 | Consulting Fee VYVGART · Immunology | $5,000 |
| Janssen Research & Development, LLC Dec 12, 2025 | Consulting Fee | $3,438 |
| Sobi, Inc Mar 21, 2025 | Travel and Lodging Doptelet · Hematology/Oncology · travel to Atlanta, GA | $704 |
| Argenx US, Inc. Aug 6, 2025 | Consulting Fee | $625 |
| Sobi, Inc Mar 21, 2025 | Travel and Lodging Doptelet · Hematology/Oncology · travel to Atlanta, GA | $291 |
| Sobi, Inc Apr 10, 2025 | Travel and Lodging Doptelet · Hematology/Oncology · travel to Atlanta, GA | $105 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $75,907 in research payments for these studies, mostly to the institutions running them.
- Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
Sanofi US Services Inc. · Completed · NCT04562766 - AVA-PED-301
Sobi, Inc - Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia A Multi Center Randomized Double blind Placebo controlled Study
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.